Skip to main content

Market Overview

15 Stocks Moving In Thursday's After-Hours Session

Share:
15 Stocks Moving In Thursday's After-Hours Session

Gainers

  • Clearfield (NASDAQ: CLFD) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
  • Scientific Games (NASDAQ: SGMS) shares are trading higher after the company reported better-than-expected Q2 sales results.
  • Advanced Micro Devices (NYSE: AMD) shares are trading higher after Intel reported Q2 earnings results and traded lower.
  • Adaptimmune Therapeutics (NASDAQ: ADAP) shares are trading higher after the company reported it was granted access to priority medicines regulatory support by EMA for ADP-A2M4 for treatment of Synovial Sarcoma.
  • Theratechnologies (NASDAQ: THTX) shares are trading higher after the company reported that Tesamorelin improves liver health.
  • SciPlay (NASDAQ: SCPL) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
  • Mattel (NYSE: MAT) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
  • BJ's Restaurants (NASDAQ: BJRI) shares are trading higher after the company reported better-than-expected Q2 EPS results.
  • Skechers USA (NYSE: SKX) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
  • Edwards Lifesciences (NYSE: EW) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY20 EPS guidance above estimates.
  • Radius Health (NASDAQ: RDUS) shares are trading higher after the company, and Menarini Group, announced they entered into an exclusive global license agreement for the development and commercialization of elacestrant.
  • LeMaitre Vascular (NASDAQ: LMAT) shares are trading higher after the company reported better-than expected Q2 EPS and sales results. The company also issued Q3 EPS and sales guidance.
  • miRagen Therapeutics (NASDAQ: MGEN) shares are trading higher after the company received orphan drug designation for cobomarsen from the FDA for the treatment of T-cell lymphoma.

Losers

  • Intel (NASDAQ: INTC) shares are trading lower despite the company reporting better-than-expected Q2 EPS and earnings results.
  • EHealth (NASDAQ: EHTH) shares are trading lower after the company reported Q2 earnings results.
 

Related Articles (AMD + ADAP)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks After-Hours Center Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com